Claudia Urueña

1.1k total citations
43 papers, 766 citations indexed

About

Claudia Urueña is a scholar working on Molecular Biology, Applied Microbiology and Biotechnology and Immunology. According to data from OpenAlex, Claudia Urueña has authored 43 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Applied Microbiology and Biotechnology and 11 papers in Immunology. Recurrent topics in Claudia Urueña's work include Tannin, Tannase and Anticancer Activities (13 papers), Biological Stains and Phytochemicals (9 papers) and Immunotherapy and Immune Responses (9 papers). Claudia Urueña is often cited by papers focused on Tannin, Tannase and Anticancer Activities (13 papers), Biological Stains and Phytochemicals (9 papers) and Immunotherapy and Immune Responses (9 papers). Claudia Urueña collaborates with scholars based in Colombia, Switzerland and United States. Claudia Urueña's co-authors include Susana Fiorentino, Alfonso Barreto, Bernardo Camacho, César Augusto Ramírez, Alejandra Gomez‐Cadena, Tito A. Sandoval, Paola Lasso, Alexzander Asea, Alena Donda and Amaia Martínez-Usatorre and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Scientific Reports.

In The Last Decade

Claudia Urueña

40 papers receiving 749 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudia Urueña Colombia 16 306 245 176 124 83 43 766
Jumin Huang Macao 15 419 1.4× 207 0.8× 136 0.8× 59 0.5× 65 0.8× 25 832
Ke-Wang Luo China 17 397 1.3× 199 0.8× 109 0.6× 129 1.0× 74 0.9× 29 918
Shakti Prasad Pattanayak India 19 395 1.3× 108 0.4× 101 0.6× 214 1.7× 153 1.8× 57 1.0k
Jae In Jung South Korea 17 548 1.8× 151 0.6× 126 0.7× 97 0.8× 52 0.6× 50 1.0k
Siddharth S. Kesharwani United States 18 384 1.3× 148 0.6× 144 0.8× 71 0.6× 41 0.5× 30 1.1k
Lehe Yang China 18 396 1.3× 275 1.1× 72 0.4× 55 0.4× 62 0.7× 42 878
Nipin Sp South Korea 19 587 1.9× 202 0.8× 133 0.8× 130 1.0× 57 0.7× 41 1.2k
Miao Yu China 14 301 1.0× 174 0.7× 148 0.8× 114 0.9× 31 0.4× 50 699
Susan J. Zunino United States 21 637 2.1× 176 0.7× 277 1.6× 88 0.7× 38 0.5× 40 1.4k
Tianqi Ming China 11 595 1.9× 186 0.8× 83 0.5× 85 0.7× 57 0.7× 16 1.1k

Countries citing papers authored by Claudia Urueña

Since Specialization
Citations

This map shows the geographic impact of Claudia Urueña's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Urueña with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Urueña more than expected).

Fields of papers citing papers by Claudia Urueña

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Urueña. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Urueña. The network helps show where Claudia Urueña may publish in the future.

Co-authorship network of co-authors of Claudia Urueña

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Urueña. A scholar is included among the top collaborators of Claudia Urueña based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Urueña. Claudia Urueña is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Torregrosa, Lilián, et al.. (2023). Safety and efficacy of P2Et extract from Caesalpinia spinosa in breast cancer patients: study protocol for a randomized double blind phase II clinical trial (CS003-BC). BMC Complementary Medicine and Therapies. 23(1). 309–309. 2 indexed citations
4.
Lasso, Paola, et al.. (2023). Plant extracts modulate cellular stress to inhibit replication of mouse Coronavirus MHV-A59. Heliyon. 10(1). e23403–e23403. 1 indexed citations
5.
Lasso, Paola, Claudia Urueña, Tito A. Sandoval, et al.. (2023). Piper nigrum extract suppresses tumor growth and enhances the antitumor immune response in murine models of breast cancer and melanoma. Cancer Immunology Immunotherapy. 72(10). 3279–3292. 11 indexed citations
6.
Lasso, Paola, et al.. (2023). Petiveria alliacea Reduces Tumor Burden and Metastasis and Regulates the Peripheral Immune Response in a Murine Myeloid Leukemia Model. International Journal of Molecular Sciences. 24(16). 12972–12972. 5 indexed citations
7.
Urueña, Claudia, et al.. (2023). Effect of Petiveria alliacea Extracts on Metabolism of K562 Myeloid Leukemia Cells. International Journal of Molecular Sciences. 24(24). 17418–17418. 1 indexed citations
8.
Urueña, Claudia, et al.. (2023). Encapsulated Phytomedicines against Cancer: Overcoming the “Valley of Death”. Pharmaceutics. 15(4). 1038–1038. 1 indexed citations
9.
Urueña, Claudia, Alejandra Gomez‐Cadena, Alfonso Barreto, et al.. (2022). Randomized double-blind clinical study in patients with COVID-19 to evaluate the safety and efficacy of a phytomedicine (P2Et). Frontiers in Medicine. 9. 991873–991873. 9 indexed citations
10.
Urueña, Claudia, et al.. (2022). CAR-T Cell Performance: How to Improve Their Persistence?. Frontiers in Immunology. 13. 878209–878209. 120 indexed citations
11.
Lasso, Paola, et al.. (2022). Tillandsia usneoides Extract Decreases the Primary Tumor in a Murine Breast Cancer Model but Not in Melanoma. Cancers. 14(21). 5383–5383. 10 indexed citations
12.
Cao, Yu, Eslam Mohamed, Jimena Trillo-Tinoco, et al.. (2019). Polyphenol-rich extract induces apoptosis with immunogenic markers in melanoma cells through the ER stress-associated kinase PERK. Cell Death Discovery. 5(1). 134–134. 43 indexed citations
13.
Lasso, Paola, Alejandra Gomez‐Cadena, Claudia Urueña, et al.. (2018). Prophylactic vs. Therapeutic Treatment With P2Et Polyphenol-Rich Extract Has Opposite Effects on Tumor Growth. Frontiers in Oncology. 8. 356–356. 26 indexed citations
14.
Gomez‐Cadena, Alejandra, Claudia Urueña, Amaia Martínez-Usatorre, et al.. (2016). Immune-system-dependent anti-tumor activity of a plant-derived polyphenol rich fraction in a melanoma mouse model. Cell Death and Disease. 7(6). e2243–e2243. 52 indexed citations
15.
Gomez‐Cadena, Alejandra, Amaia Martínez-Usatorre, Claudia Urueña, et al.. (2015). Immune system activation through immunogenic cell death and tumor recruitment of dendritic cells is required for anti-tumor activity of a plant-derived polyphenol rich fraction. Journal for ImmunoTherapy of Cancer. 3(S2). 3 indexed citations
17.
Fiorentino, Susana, et al.. (2009). A fraction from Petiveria alliacea induces apoptosis via a mitochondria-dependent pathway and regulates HSP70 expression. SHILAP Revista de lepidopterología. 1 indexed citations
18.
Urueña, Claudia, et al.. (2007). Un flavonoide de chromolaena tacotana induce depolarizacion de la membrana mitocondrial en celulas normales. Scientia et technica (Universidad Tecnológica de Pereira). 1(33). 317. 1 indexed citations
19.
Urueña, Claudia, et al.. (2007). Un flavonoide de chromolaena perglabra induce muerte celular en celulas tumorales y proliferacion en celulas normales. Scientia et technica (Universidad Tecnológica de Pereira). 1(33). 315.
20.
Urueña, Claudia, et al.. (1998). Alpha-1 Antichymotrypsin Levels Are Actively Increased in Normal Colostrum. Journal of Pediatric Gastroenterology and Nutrition. 26(4). 376–379. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026